Mostly Cloudy
74°
Morris, IL
Mostly Cloudy|Forecast »

Expert sees ‘health care crisis’ in Alzheimer’s care as baby boomers age

  Comments (...)
Text Size: AaAaAaAaAa

(MCT) — LEXINGTON, Ky. — Lingering stigma and a lack of resources will compound the growing impact of Alzheimer’s disease as baby boomers enter retirement. And Linda J. Van Eldik, director of Lexington’s Sanders-Brown Center on Aging, is calling it a health care crisis.

According to the national Alzheimer’s Association, the number of new cases of Alzheimer’s will have increased by 50 percent between 2000 and 2050. In Kentucky, the number of patients is expected to grow by at least 31 percent.

The Alzheimer’s Association projects that the cost of caring for those patients will increase from $183 billion in 2011 to $1.1 trillion in 2050.

“I am very concerned that the economy isn’t going to be able to handle this massive health care crisis,” said Van Eldik.

While Alzheimer’s is not a normal part of aging, increased age is a risk factor for the disease, said Van Eldik. Roughly 5 percent of those who reach 65 will be diagnosed with Alzheimer’s, she said. By the time people are in their 80s, 40 to 50 percent will be impacted by the disease.

The current health care system isn’t set up to deal with the large number of Alzheimer’s patients on the horizon, she said.

According to the Alzheimer’s Association, unpaid caregivers tend to 60 percent of the current patients. Most of those caregivers also have full-time jobs and other responsibilities, such as children under the age of 18. That “sandwich” generation will continue to carry much of the burden for care, Van Eldik said.

While Alzheimer’s research, including the work done at Sanders-Brown, has made great strides in the last decade, there is still little that can be done to help patients once memory troubles begin.

According to the Alzheimer’s Association, no treatment is available to slow or stop the deterioration of brain cells in Alzheimer’s disease.

The U.S. Food and Drug Administration has approved five drugs that temporarily slow worsening of symptoms for about six to 12 months. They are effective in only about half of the patients. Approximately 75 to 100 experimental therapies aimed at slowing or stopping the progression of Alzheimer’s are being tested around the world, including some trials at Sanders-Brown.

Previous Page|1||

Comments

Total Comments
0

View/Add Comments

There have been no comments made about this story.

Reader Poll

Were you impacted by last week's flooding?

Yes, but only inconvenienced by closed streets
Yes, water got close, but everything worked out OK
Yes, I had to evacuate my home or workplace
Yes, my house sustained extensive damage
No, I managed to avoid it all